Page last updated: 2024-11-03

prazosin and Liver Steatosis

prazosin has been researched along with Liver Steatosis in 2 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oben, JA1
Roskams, T1
Yang, S1
Lin, H1
Sinelli, N1
Li, Z1
Torbenson, M1
Huang, J1
Guarino, P1
Kafrouni, M1
Diehl, AM1
Zwierzina, WD1
Kunz, F1
Judmaier, G1
Mikuz, G1
Gattringer, K1

Other Studies

2 other studies available for prazosin and Liver Steatosis

ArticleYear
Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury.
    Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:3

    Topics: Adrenergic alpha-Antagonists; Animals; Antioxidants; Body Weight; Diet; Fatty Liver; Hepatocytes; Li

2003
[Acute fatty liver in pregnancy with consumption coagulopathy].
    Deutsche medizinische Wochenschrift (1946), 1983, May-06, Volume: 108, Issue:18

    Topics: Acute Disease; Adult; Ampicillin; Ascites; Disseminated Intravascular Coagulation; Electrolytes; Fat

1983